[lotsofpulp]

>I understand that one needs to recoup R&D costs a few times over for it to be worth the risk, but that's simply cost price (risk * R&D cost / unit count * unit cost) and not a "premium product".

How are you going to attract top minds to do the R&D without paying them a premium? And investors need a premium to incentivize investing R&D, especially in the low probability of success field of biotech.

I don't agree with the way their CEO characterized it. He probably should have just said the pricing is commensurate with the costs involved in developing it or something, which include the opportunity cost of not using the funds to buy tech stocks.